Stem cell models for drug discovery and toxicology studies

Area of Science:

• Biotechnology
• Toxicology
• Regenerative Medicine

Background:

• Conventional animal models for toxicity testing have limitations in human relevance.
• Human stem cells, including embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), offer promising alternatives.
• iPSCs enable personalized toxicity assessments based on individual genetic and environmental factors.

Purpose of the Study:

• To explore the potential of human stem cell-based assays in toxicology.
• To identify how stem cells can improve drug discovery and risk assessment.
• To address limitations in current toxicology approaches and propose solutions.

Main Methods:

• Utilizing human embryonic stem cells (hESCs) and human-induced pluripotent stem cells (iPSCs) for in vitro toxicity models.
• Employing comprehensive profiling techniques like genomics, proteomics, transcriptomics, and metabolomics.
• Analyzing pathway perturbations to understand toxicity mechanisms.

Main Results:

• Human stem cells provide relevant, humanized models for toxicity screening and mechanistic studies.
• Stem cell assays can elucidate genetic and environmental influences on toxicity response.
• Multi-omics profiling aids in developing predictive toxicity assays.

Conclusions:

• Human stem cell-based assays hold significant potential for safer, personalized medicines and accurate environmental risk assessment.
• Overcoming technological hurdles is crucial for integrating these assays into standard practice.
• Increased adoption of human in vitro models can reduce animal testing and enhance understanding of toxicity's molecular basis.